Please login or register first to view this content.
Immunization Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
NCCN Endorses Full COVID-19 Vaccination for Cancer Patients
Pfizer Says Omicron-Specific Vaccine Ready by March
Study Supports Coadministration of Prevnar 20 With Pfizer-BioNTech COVID-19 Vaccine
FDA Shortens Booster Dose Interval for Moderna COVID-19 Vaccine
Moderna CEO Says Fourth COVID-19 Dose May Be Needed Next Fall
CDC Recommends COVID-19 Vaccine Booster Dose for 12- to 15-Year-Olds
FDA Grants Fast Track Status to Intranasal Pertussis Vaccine
CDC Shortens Recommended COVID-19 Isolation, Quarantine Period
NVX-CoV2373 Vaccine Protects Against COVID-19
Biden Outlines Measures to Fight Omicron, Pleads With Americans to Get Vaccinated
Test-to-Stay Strategy Seems Effective for Saving In-Person Learning
Supplemental BLA Submitted for Pfizer-BioNTech COVID-19 Vaccine for 12- to 15-Year-Olds
CDC Panel Advises That Other Vaccines Are Preferred Over J&J Shot
MPR Weekly Dose Podcast Episode 102
Two Doses of mRNA-1273 Effective Against SARS-CoV-2 Variants
Contraindication Added to Janssen COVID-19 Vaccine Fact Sheet
Report Highlights Characteristics of Omicron SARS-CoV-2 Variant in US
Pfizer-BioNTech COVID-19 Booster Authorized for 16- and 17-Year-Olds
